The Valley Desk

NCT05259033 · Interventional trial

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Overall registry status Completed

Phase 3

Conditions Diabetes Mellitus, Type 2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov